Hi Reg,
yep, I prefer your higher numbers too. Agree re adult dosage being higher - remember, we're going to do an end-run on Ruxolitinib with an inclusion criteria that requires failure of at least one approved therapy & NIH/ BMT CTN seem OK with the restriction.
Cheers
Hi Reg, yep, I prefer your higher numbers too. Agree re adult...
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.09 |
Change
0.005(0.46%) |
Mkt cap ! $1.221B | |||
| Open | High | Low | Value | Volume |
| $1.07 | $1.10 | $1.05 | $4.368M | 4.075M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 8 | 19138 | $1.09 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.09 | 114940 | 22 |
View Market Depth
| Last trade - 15.43pm 17/06/2024 (20 minute delay) ? |
|
|||||
|
Last
$1.09 |
Change
0.005 ( 0.40 %) |
||||
| Open | High | Low | Volume | ||
| $1.07 | $1.10 | $1.05 | 1011230 | ||
| Last updated 15.59pm 17/06/2024 ? | |||||
| MSB (ASX) Chart |
